Showing results (61-70 of 77) with videos related to
Sort By:
Pageof 8
Food and Environmental Virology|September 2, 2016
Hepatitis E Virus in Pork and Variety Meats Sold in Fresh MarketsDuangnapa Intharasongkroh, Pattaratida Sa-Nguanmoo, Supansa Tuanthap, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 19, 2023
Neutralizing antibodies against Omicron BA.5 among children with infection alone, vaccination alone, and hybrid immunityNungruthai Suntronwong, Sitthichai Kanokudom, Suvichada Assawakosri, et al.Vaccines|July 27, 2022
Immunogenicity Following Two Doses of the BBIBP-CorV Vaccine and a Third Booster Dose with a Viral Vector and mRNA COVID-19 Vaccines against Delta and Omicron Variants in Prime Immunized Adults with Two Doses of the BBIBP-CorV VaccineJira Chansaenroj, Nungruthai Suntronwong, Sitthichai Kanokudom, et al.Vaccines|March 30, 2023
The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.5Sitthichai Kanokudom, Jira Chansaenroj, Nungruthai Suntronwong, et al.Diagnostics (Basel, Switzerland)|July 27, 2022
Strong Correlations between the Binding Antibodies against Wild-Type and Neutralizing Antibodies against Omicron BA.1 and BA.2 Variants of SARS-CoV-2 in Individuals Following Booster (Third-Dose) VaccinationNungruthai Suntronwong, Suvichada Assawakosri, Sitthichai Kanokudom, et al.Journal of Medical Virology|August 4, 2022
Effects of boosted mRNA and adenoviral-vectored vaccines on immune responses to omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccinationNungruthai Suntronwong, Sitthichai Kanokudom, Chompoonut Auphimai, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 21, 2022
Persistence of immunity against Omicron BA.1 and BA.2 variants following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-dose AZD1222 vaccinationSuvichada Assawakosri, Sitthichai Kanokudom, Jira Chansaenroj, et al.Heliyon|January 16, 2024
Immunogenicity and durability against Omicron BA.1, BA.2 and BA.4/5 variants at 3-4 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses CoronaVac vaccinationSuvichada Assawakosri, Sitthichai Kanokudom, Nungruthai Suntronwong, et al.Vaccines|July 29, 2023
SARS-CoV-2 Antibody Dynamics after COVID-19 Vaccination and Infection: A Real-World Cross-Sectional AnalysisRitthideach Yorsaeng, Kamolthip Atsawawaranunt, Nungruthai Suntronwong, et al.Journal of Medical Virology|May 22, 2023
Comparison of the reactogenicity and immunogenicity between two-dose mRNA COVID-19 vaccine and inactivated COVID-19 vaccine followed by an mRNA vaccine in children aged 5-11 yearsNasamon Wanlapakorn, Sitthichai Kanokudom, Harit Phowatthanasathian, et al.Pageof 8